{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:55:42Z","timestamp":1762509342680,"version":"3.44.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,20]]},"DOI":"10.7759\/cureus.92768","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:09:16Z","timestamp":1758355756000},"source":"Crossref","is-referenced-by-count":1,"title":["Fludrocortisone for Refractory Hypotension in a Hospitalized Dialysis Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Fnu","family":"Veerban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Kurup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moro","family":"Salifu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy I","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Mallappallil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.13131","article-title":"Adrenal insufficiency in hemodialysis patients-an under-recognized problem: a case series","volume":"28","author":"Shah K","year":"2024","unstructured":"Shah K, Wong J, Mac K, Lau NS, Wong VM, Makris A. Adrenal insufficiency in hemodialysis patients-an under-recognized problem: a case series. Hemodial Int. 2024, 28:229-32. 10.1111\/hdi.13131","journal-title":"Hemodial Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.2018.37.1.85","article-title":"Use of fludrocortisone for intradialytic hypotension","volume":"37","author":"Seo Y","year":"2018","unstructured":"Seo Y, Jeung S, Kang SM, Yang WS, Kim H, Kim SB. Use of fludrocortisone for intradialytic hypotension. Kidney Res Clin Pract. 2018, 37:85-8. 10.23876\/j.krcp.2018.37.1.85","journal-title":"Kidney Res Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010030280","article-title":"Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD","volume":"21","author":"Locatelli F","year":"2010","unstructured":"Locatelli F, Altieri P, Andrulli S, et al.. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010, 21:1798-807. 10.1681\/ASN.2010030280","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.01.046","article-title":"Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"Flythe JE","year":"2020","unstructured":"Flythe JE, Chang TI, Gallagher MP, et al.. Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020, 97:861-76. 10.1016\/j.kint.2020.01.046","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw433","article-title":"Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)","volume":"32","author":"Sarafidis PA","year":"2017","unstructured":"Sarafidis PA, Persu A, Agarwal R, et al.. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol Dial Transplant. 2017, 32:620-40. 10.1093\/ndt\/gfw433","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/EC9.0000000000000124","article-title":"Severe metabolic alkalosis with fludrocortisone therapy\u2014a case report","author":"Williams G","year":"2023","unstructured":"Williams G, Hinxman H. Severe metabolic alkalosis with fludrocortisone therapy\u2014a case report. Emerg Crit Care Med. 2023, 10.1097\/EC9.0000000000000124","journal-title":"Emerg Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-106","article-title":"Association of intradialytic hypotension and convective volume in hemodiafiltration: results from a retrospective cohort study","volume":"13","author":"Mora-Bravo FG","year":"2012","unstructured":"Mora-Bravo FG, De-La-Cruz G, Rivera S, Ram\u00edrez AM, Raimann JG, P\u00e9rez-Grovas H. Association of intradialytic hypotension and convective volume in hemodiafiltration: results from a retrospective cohort study. BMC Nephrol. 2012, 13:106. 10.1186\/1471-2369-13-106","journal-title":"BMC Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13260","article-title":"Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial","volume":"24","author":"Schreglmann SR","year":"2017","unstructured":"Schreglmann SR, B\u00fcchele F, Sommerauer M, et al.. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial. Eur J Neurol. 2017, 24:545-51. 10.1111\/ene.13260","journal-title":"Eur J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6014.872","article-title":"Therapeutic experience with fludrocortisone in diabetic postural hypotension","volume":"1","author":"Campbell IW","year":"1976","unstructured":"Campbell IW, Ewing DJ, Clarke BF. Therapeutic experience with fludrocortisone in diabetic postural hypotension. Br Med J. 1976, 1:872-4. 10.1136\/bmj.1.6014.872","journal-title":"Br Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000527608","article-title":"Effect of fludrocortisone on intradialytic hypotension: an open-label, randomized, crossover study","volume":"52","author":"Vongchaiudomchoke T","year":"2023","unstructured":"Vongchaiudomchoke T, Siriyong P, Wachiraphansakul N, Noppakun K. Effect of fludrocortisone on intradialytic hypotension: an open-label, randomized, crossover study. Blood Purif. 2023, 52:264-74. 10.1159\/000527608","journal-title":"Blood Purif"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm386","article-title":"Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis","volume":"22","author":"Kim DM","year":"2007","unstructured":"Kim DM, Chung JH, Yoon SH, Kim HL. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis. Nephrol Dial Transplant. 2007, 22:3273-6. 10.1093\/ndt\/gfm386","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.12123","article-title":"Potassium balance in dialysis patients","volume":"26","author":"Sanghavi S","year":"2013","unstructured":"Sanghavi S, Whiting S, Uribarri J. Potassium balance in dialysis patients. Semin Dial. 2013, 26:597-603. 10.1111\/sdi.12123","journal-title":"Semin Dial"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.01.014","article-title":"A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients","volume":"47","author":"Kaisar MO","year":"2006","unstructured":"Kaisar MO, Wiggins KJ, Sturtevant JM, et al.. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients. Am J Kidney Dis. 2006, 47:809-14. 10.1053\/j.ajkd.2006.01.014","journal-title":"Am J Kidney Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2024.22.1.8","article-title":"Use of fludrocortisone for hyperkalemia in chronic kidney disease not yet on dialysis","volume":"22","author":"Lee EK","year":"2024","unstructured":"Lee EK, Yang WS. Use of fludrocortisone for hyperkalemia in chronic kidney disease not yet on dialysis. Electrolyte Blood Press. 2024, 22:8-15. 10.5049\/EBP.2024.22.1.8","journal-title":"Electrolyte Blood Press"},{"key":"ref15","unstructured":"Fludrocortisone. drug information. (2025). Accessed: 07\/25\/2025: https:\/\/www.uptodate.com\/contents\/fludrocortisone-drug-information?search=fludrocortisone&source=panel_search_result&...."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.22159\/ijpps.2024v16i11.52092","article-title":"Optimizing drug dosing in critically ill patients with augmented renal clearance: a comprehensive review and meta-analysis","volume":"20","author":"Chachar M","year":"2009","unstructured":"Chachar M, Lokhande T, Kumbhar A, Chavan R, Shinde D. Optimizing drug dosing in critically ill patients with augmented renal clearance: a comprehensive review and meta-analysis. J Am Soc Nephrol. 2009, 20:629-37. 10.22159\/ijpps.2024v16i11.52092","journal-title":"J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/400929-fludrocortisone-for-refractory-hypotension-in-a-hospitalized-dialysis-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:09:18Z","timestamp":1758355758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/400929-fludrocortisone-for-refractory-hypotension-in-a-hospitalized-dialysis-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.92768","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,20]]}}}